262 related articles for article (PubMed ID: 34357335)
1. Hyperpolarized Dihydroxyacetone Is a Sensitive Probe of Hepatic Gluconeogenic State.
Ragavan M; McLeod MA; Giacalone AG; Merritt ME
Metabolites; 2021 Jul; 11(7):. PubMed ID: 34357335
[TBL] [Abstract][Full Text] [Related]
2. Real-time detection of hepatic gluconeogenic and glycogenolytic states using hyperpolarized [2-13C]dihydroxyacetone.
Moreno KX; Satapati S; DeBerardinis RJ; Burgess SC; Malloy CR; Merritt ME
J Biol Chem; 2014 Dec; 289(52):35859-67. PubMed ID: 25352600
[TBL] [Abstract][Full Text] [Related]
3. Kinetic Analysis of Hepatic Metabolism Using Hyperpolarized Dihydroxyacetone.
Kirpich A; Ragavan M; Bankson JA; McIntyre LM; Merritt ME
J Chem Inf Model; 2019 Jan; 59(1):605-614. PubMed ID: 30602117
[TBL] [Abstract][Full Text] [Related]
4. In vivo hyperpolarized carbon-13 magnetic resonance spectroscopy reveals increased pyruvate carboxylase flux in an insulin-resistant mouse model.
Lee P; Leong W; Tan T; Lim M; Han W; Radda GK
Hepatology; 2013 Feb; 57(2):515-24. PubMed ID: 22911492
[TBL] [Abstract][Full Text] [Related]
5. PPP1R3C mediates metformin-inhibited hepatic gluconeogenesis.
Ji X; Wang S; Tang H; Zhang Y; Zhou F; Zhang L; Zhu Q; Zhu K; Liu Q; Liu Y; Wang X; Zhou L
Metabolism; 2019 Sep; 98():62-75. PubMed ID: 31181215
[TBL] [Abstract][Full Text] [Related]
6. The nuclear bile acid receptor FXR is a PKA- and FOXA2-sensitive activator of fasting hepatic gluconeogenesis.
Ploton M; Mazuy C; Gheeraert C; Dubois V; Berthier A; Dubois-Chevalier J; Maréchal X; Bantubungi K; Diemer H; Cianférani S; Strub JM; Helleboid-Chapman A; Eeckhoute J; Staels B; Lefebvre P
J Hepatol; 2018 Nov; 69(5):1099-1109. PubMed ID: 29981427
[TBL] [Abstract][Full Text] [Related]
7. Probing hepatic metabolism of [2-
Marco-Rius I; Wright AJ; Hu DE; Savic D; Miller JJ; Timm KN; Tyler D; Brindle KM; Comment A
MAGMA; 2021 Feb; 34(1):49-56. PubMed ID: 32910316
[TBL] [Abstract][Full Text] [Related]
8. Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice.
Zhang Y; Guan Q; Liu Y; Zhang Y; Chen Y; Chen J; Liu Y; Su Z
J Biol Chem; 2018 May; 293(20):7894-7904. PubMed ID: 29530977
[TBL] [Abstract][Full Text] [Related]
9. Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo.
Madiraju AK; Qiu Y; Perry RJ; Rahimi Y; Zhang XM; Zhang D; Camporez JG; Cline GW; Butrico GM; Kemp BE; Casals G; Steinberg GR; Vatner DF; Petersen KF; Shulman GI
Nat Med; 2018 Sep; 24(9):1384-1394. PubMed ID: 30038219
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of oestrogen and progesterone effects on lipid and carbohydrate metabolism: alteration in the insulin: glucagon molar ratio and hepatic enzyme activity.
Mandour T; Kissebah AH; Wynn V
Eur J Clin Invest; 1977 Jun; 7(3):181-7. PubMed ID: 19260
[TBL] [Abstract][Full Text] [Related]
11. Role of hepatic neuregulin 4 in the regulation of gluconeogenesis in mice.
Zhang L; Bai M; Tang H; Zhou F; Zhu Q; Wang S; Zhu K; Liu Q; Liu Y; Wang X; Ma Y; Zhou L
Life Sci; 2019 Jan; 217():185-192. PubMed ID: 30528184
[TBL] [Abstract][Full Text] [Related]
12. Multiband spectral-spatial RF excitation for hyperpolarized [2-
Marco-Rius I; Cao P; von Morze C; Merritt M; Moreno KX; Chang GY; Ohliger MA; Pearce D; Kurhanewicz J; Larson PE; Vigneron DB
Magn Reson Med; 2017 Apr; 77(4):1419-1428. PubMed ID: 27017966
[TBL] [Abstract][Full Text] [Related]
13. The possible role of age-related increase in the plasma glucagon/insulin ratio in the enhanced hepatic gluconeogenesis and hyperglycemia in genetically diabetic (C57BL/KsJ-db/db) mice.
Kodama H; Fujita M; Yamazaki M; Yamaguchi I
Jpn J Pharmacol; 1994 Nov; 66(3):281-7. PubMed ID: 7869614
[TBL] [Abstract][Full Text] [Related]
14. RNA sequencing of db/db mice liver identifies lncRNA H19 as a key regulator of gluconeogenesis and hepatic glucose output.
Goyal N; Sivadas A; Shamsudheen KV; Jayarajan R; Verma A; Sivasubbu S; Scaria V; Datta M
Sci Rep; 2017 Aug; 7(1):8312. PubMed ID: 28814771
[TBL] [Abstract][Full Text] [Related]
15. Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study.
Hellerstein MK; Neese RA; Linfoot P; Christiansen M; Turner S; Letscher A
J Clin Invest; 1997 Sep; 100(5):1305-19. PubMed ID: 9276749
[TBL] [Abstract][Full Text] [Related]
16. Suppressor of cytokine signalling-2 controls hepatic gluconeogenesis and hyperglycemia by modulating JAK2/STAT5 signalling pathway.
Zhang X; Zhuang Y; Qin T; Chang M; Ji X; Wang N; Zhang Z; Zhou H; Wang Q; Li JZ
Metabolism; 2021 Sep; 122():154823. PubMed ID: 34197875
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA H19 inhibition promotes hyperglycemia in mice by upregulating hepatic FoxO1 levels and promoting gluconeogenesis.
Goyal N; Tiwary S; Kesharwani D; Datta M
J Mol Med (Berl); 2019 Jan; 97(1):115-126. PubMed ID: 30465059
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice.
Altomonte J; Richter A; Harbaran S; Suriawinata J; Nakae J; Thung SN; Meseck M; Accili D; Dong H
Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E718-28. PubMed ID: 12783775
[TBL] [Abstract][Full Text] [Related]
19. Hepatic metabolism of genetically diabetic (db/db) mice. I. Carbohydrate metabolism.
Chan TM; Young KM; Hutson NJ; Brumley FT; Exton JH
Am J Physiol; 1975 Dec; 229(6):1702-12. PubMed ID: 174448
[TBL] [Abstract][Full Text] [Related]
20. Effects of metformin on glucose and glucagon regulated gluconeogenesis in cultured normal and diabetic hepatocytes.
Yu B; Pugazhenthi S; Khandelwal RL
Biochem Pharmacol; 1994 Aug; 48(5):949-54. PubMed ID: 8093107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
